IP Verse

Luigi, Rumi opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Luigi, Rumi

Patent Number:
EP2482812
Title:
Therapeutic Uses Of Pharmaceutical Compositions
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Oct 11, 2023
Patent Number:
EP4011915
Title:
Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist
Applicant:
REGENERON PHARMACEUTICALS, INC.
Opposition Date:
Oct 11, 2023
Patent Number:
EP3464277
Title:
Pegylated Carfilzomib Compounds
Applicant:
AMGEN INC.
Opposition Date:
Sep 27, 2023
Patent Number:
EP3632448
Title:
Pharmaceutical Composition Comprising Drospirenone And Contraceptive Kit
Applicant:
LABORATORIOS LEON FARMA SA
Opposition Date:
Oct 12, 2022
Patent Number:
EP3054929
Title:
Muco-Adhesive, Controlled Release Formulations Of Levodopa And/Or Esters Of Levodopa And Uses Thereof
Applicant:
IMPAX LABORATORIES, INC.
Opposition Date:
May 5, 2021
Patent Number:
EP3383385
Title:
Melflufen Dosage Regimens For Cancer
Applicant:
ONCOPEPTIDES AB
Opposition Date:
Apr 29, 2021
Patent Number:
EP2234963
Title:
Controlled Release Formulations Of Levodopa And Uses Thereof
Applicant:
IMPAX LABORATORIES, INC.
Opposition Date:
Jan 7, 2021
Patent Number:
EP2897611
Title:
Methods For Treating Hepatitis C
Applicant:
ABBVIE INC.
Opposition Date:
Apr 24, 2020
Patent Number:
EP2867670
Title:
Means And Methods Applying Sflt-1/Plgf Or Endoglin/Plgf Ratio To Rule-Out Onset Of Preeclampsia Within A Certain Time Period
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Feb 27, 2019
Patent Number:
EP2858985
Title:
Crystalline Forms Of An Androgen Receptor Modulator
Applicant:
ARAGON PHARMACEUTICALS, INC.
Opposition Date:
Jan 18, 2019

Competitors of Luigi, Rumi

IMPAX LABORATORIES, INC.

IMPAX LABORATORIES, LLC

ABBVIE INC.

Want to track Luigi, Rumi?

Feel free to send us a message here and we will get back to you